Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9Melanoma 4Neoplasms 3Multiple Myeloma 3Skin Neoplasms 2Polycystic Ovary Syndrome 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1Skin Toxicity 1Resectable Pancreatic Ductal Adenocarcinoma 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Obesity 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Meningioma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Inflammation 1

Interventions

Morphine 2resiniferatoxin 1incobotulinumtoxinA 1fulranumab 1cannabichromene 1alvimopan 1Tablets 1Surveys and Questionnaires 1Standard of Care 1Pain Management 1Oxycodone 1Occupational Therapy 1Massage 1Lidocaine 1Lenalidomide 1Ketamine 1Gels 1Fentanyl 1Dronabinol 1Cannabidiol 1Animal Assisted Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Pain × Tablets × Clear all
NCT04162379 2020-03-10

Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol

Mansoura University

Phase 2 Completed
39 enrolled

Cancer Pain, Agnosia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡